| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.001 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.0024 | 1 |